CS250661B2 - Method of hydantoin's derivatives production - Google Patents

Method of hydantoin's derivatives production Download PDF

Info

Publication number
CS250661B2
CS250661B2 CS843101A CS310184A CS250661B2 CS 250661 B2 CS250661 B2 CS 250661B2 CS 843101 A CS843101 A CS 843101A CS 310184 A CS310184 A CS 310184A CS 250661 B2 CS250661 B2 CS 250661B2
Authority
CS
Czechoslovakia
Prior art keywords
spiro
fluoro
chroman
imidazolidine
apos
Prior art date
Application number
CS843101A
Other languages
Czech (cs)
English (en)
Inventor
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS250661B2 publication Critical patent/CS250661B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CS843101A 1983-04-27 1984-04-26 Method of hydantoin's derivatives production CS250661B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/488,947 US4474967A (en) 1983-04-27 1983-04-27 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione

Publications (1)

Publication Number Publication Date
CS250661B2 true CS250661B2 (en) 1987-05-14

Family

ID=23941785

Family Applications (1)

Application Number Title Priority Date Filing Date
CS843101A CS250661B2 (en) 1983-04-27 1984-04-26 Method of hydantoin's derivatives production

Country Status (22)

Country Link
US (1) US4474967A (ko)
EP (1) EP0124327A3 (ko)
JP (1) JPS59205384A (ko)
KR (1) KR860000915B1 (ko)
AU (1) AU542142B2 (ko)
CA (1) CA1226866A (ko)
CS (1) CS250661B2 (ko)
DD (1) DD219772A5 (ko)
DK (1) DK208284A (ko)
ES (1) ES8607312A1 (ko)
FI (1) FI841657A (ko)
GR (1) GR81491B (ko)
HU (1) HU191755B (ko)
IL (1) IL71656A (ko)
NO (1) NO841627L (ko)
NZ (1) NZ207959A (ko)
PH (1) PH22869A (ko)
PL (1) PL142759B1 (ko)
PT (1) PT78476B (ko)
SU (1) SU1240362A3 (ko)
YU (1) YU43358B (ko)
ZA (1) ZA843091B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE37371T1 (de) * 1984-08-20 1988-10-15 Pfizer Verfahren zur herstellung asymmetrischer hydantoine.
US4841079A (en) * 1987-08-07 1989-06-20 Pfizer, Inc. Process for the production of asymmetric hydantoins
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
GB9317764D0 (en) * 1993-08-26 1993-10-13 Pfizer Ltd Therapeutic compound
WO1999038497A2 (en) * 1998-01-30 1999-08-05 R-Tech Ueno, Ltd. Ophthalmic composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation

Also Published As

Publication number Publication date
SU1240362A3 (ru) 1986-06-23
ES531873A0 (es) 1986-06-01
PT78476B (en) 1986-08-28
YU43358B (en) 1989-06-30
DK208284D0 (da) 1984-04-26
ZA843091B (en) 1985-12-24
DD219772A5 (de) 1985-03-13
IL71656A (en) 1987-10-20
ES8607312A1 (es) 1986-06-01
KR840008355A (ko) 1984-12-14
PL247379A1 (en) 1985-03-26
IL71656A0 (en) 1984-07-31
KR860000915B1 (ko) 1986-07-18
GR81491B (ko) 1984-12-11
FI841657A0 (fi) 1984-04-26
EP0124327A2 (en) 1984-11-07
CA1226866A (en) 1987-09-15
DK208284A (da) 1984-10-28
AU2726384A (en) 1984-11-01
US4474967A (en) 1984-10-02
EP0124327A3 (en) 1985-07-31
FI841657A (fi) 1984-10-28
HU191755B (en) 1987-04-28
HUT34197A (en) 1985-02-28
AU542142B2 (en) 1985-02-07
PH22869A (en) 1989-01-19
NO841627L (no) 1984-10-29
YU74184A (en) 1986-10-31
PL142759B1 (en) 1987-11-30
JPS59205384A (ja) 1984-11-20
PT78476A (en) 1984-05-01
NZ207959A (en) 1987-04-30

Similar Documents

Publication Publication Date Title
De Sarro et al. 5H-[1, 2, 4] Oxadiazolo [5, 4-d][1, 5] benzothiazepines as anticonvulsant agents in DBA/2 mice
FI82689C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefull 2-etoxi-4-/n-(1-(2-piperidino-fenyl)-3-metyl -1-butyl)-aminokarbonylmetyl/-benzoesyras b- och c-form.
US4595693A (en) Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
CS199690B2 (cs) Způsob výroby spiro-hydantoinových derivátů
DE69018876T2 (de) Pyridazinon-Derivate.
US5250547A (en) Benzopyran derivatives
EP1102761B1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
JPH0825877B2 (ja) 眼科治療用組成物
US6693091B2 (en) Analogs of terpene trilactones from Ginkgo biloba for bioorganic and imaging studies
CS250661B2 (en) Method of hydantoin's derivatives production
NO176100B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
LU86421A1 (fr) Derives de piperazine 1,4-disubstitues,composition pharmaceutique les contenant;leur procede d'obtention
DE3721223C2 (ko)
US4464380A (en) Imidazolidinedione derivatives
Nelson et al. Stereochemical analogs of a muscarinic, ganglionic stimulant. 2. The cis and trans olefinic, epoxide, and cyclopropane analogs related to 4-[N-(3-chlorophenyl) carbamoyloxy]-2-butynyltrimethylammonium chloride
Robbins et al. (Aminoalkyl) carbamates of forskolin: intermediates for the synthesis of functionalized derivatives of forskolin with different specificities for adenylyl cyclase and the glucose transporter
JPH0441149B2 (ko)
EP0079675A1 (en) Oxazolidinedione derivatives
EP0028485B1 (en) Spiro-imidazolones for alleviating diabetes-associated conditions, processes for preparing them, and pharmaceutical compositions containing them
De Costa et al. Novel site-directed affinity ligands for GABA-gated chloride channels: synthesis, characterization, and molecular modeling of 1-(isothiocyanatophenyl)-4-tert-butyl-2, 6, 7-trioxabicyclo [2.2. 2] octanes
RU2810080C1 (ru) Трициклические производные биспидина, способ их получения и применения
FI84605C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-halogennicergolinderivat och deras syraadditionssalter.
WO2020063999A1 (en) Mono halogen or methyl-substituted 5-ht2b antagonists with increased activity
CS273186B2 (en) Method of spiroimidazolidinedione production
EP0120832A1 (fr) Alkyl-4-indolonaphtyridines et compositions pharmaceutiques les contenant